Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Goodwill & Intangible Assets | $57.9M | $77.1M | $112.8M | $130.7M | $148.1M | $199.1M | $261.0M | $258.9M | $263.6M | $297.5M | $223.8M | $314.0M | $383.8M | $535.0M | $790.3M | $873.5M | $3,383.6M | $6,598.3M | $7,378.2M | $8,941.3M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Novo Nordisk A/S's last 12-month Goodwill & Intangible Assets is $8,131.2M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Novo Nordisk A/S's Goodwill & Intangible Assets growth was 3.2%. The average annual Goodwill & Intangible Assets growth rates for Novo Nordisk A/S have been 36.3% over the past three years, 61.8% over the past five years.